From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a…
This report from PwC presents three growth strategies to empower medtech companies to win in this competitive and rapidly changing environment.
This week, the Senate and House unanimously approved the reauthorization of the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs for three years. Since early 2021, AdvaMed…
AdvaMed Accel held the 3rd Quarter meeting of the MedTech Investment Working Group.
New Episode of MedTech POV Podcast: Vibrato CEO Calls for Reauthorization of the Federal Small Business Innovation Funding Program
Juliana Elstad, President and CEO of Vibrato Medical, recently joined AdvaMed’s Scott Whitaker on The MedTech POV podcast for a conversation on several policy initiatives.
AdvaMed Accel held the 2nd Quarter meeting of the MedTech Investment Working Group.
The federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs support scientific development and product innovation benefiting patients in need and the public at large.
Investment in early-stage medtech innovation can be critical in ensuring that patients have access to novel therapeutics and diagnostics.
The Q1 2022 meeting focuses on the diagnostics industry with presentations from Susan Van Meter, Executive Director of AdvaMedDx and a discussion panel on deal-making in diagnostics.
For basic research advancing beyond the academic realm, the National Institutes of Health (NIH) provides non-dilutive federal funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer…